• Profile
Close

Matrix metalloproteinase-7 may serve as a novel biomarker for cervical cancer

OncoTargets and Therapy Jul 27, 2018

Zhu L, et al. - Researchers determined how matrix metalloproteinase-7 (MMP-7) functions in cervical cancer cells. In addition, in both tissues and serum from cervical cancer patients, they assessed its clinical significance. Cervical cancer tissues displayed higher mRNA and protein MMP-7 levels than healthy controls. Significantly decreased cervical cancer cell proliferation, migration, and invasion were achieved via silencing MMP-7, suggesting that MMP-7 have an oncogenic role in cervical cancer cells and is involved in those functions. MMP-7 expression was correlated with pathological grade, clinical stage, and lymph metastasis. The data, thereby, yield evidence supporting the potential of MMP-7 as a clinically relevant biomarker for cervical cancer.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay